Vaccine‐induced dermatomyositis following <scp>COVID</scp> ‐19 vaccination-Reference-Cited by-同舟云学术

Vaccine‐induced dermatomyositis following COVID ‐19 vaccination

Published:2022-08-18 Issue:10 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Chaima Kouki¹^ORCID,Mariem Amouri¹,Sana Bouzid¹,Khadija Sellami¹,Mariem Rekik¹,Massara Baklouti¹,Emna Bahloul¹,Sonia Boudaya¹,Abderrahman Masmoudi¹,Hamida Turki¹

Affiliation:

1. Department of Dermatology Hedi Chaker Hospital Sfax Tunisia

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15749

Reference6 articles.

1. Vaccines as a trigger for myopathies

2. Dermatomyositis – update

3. DERMATOMYOSITIS AND VACCINATION

4. New‐onset autoimmune phenomena post‐COVID‐19 vaccination;Chen Y;Immunology,2021

5. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports;Rheumatology International;2024-08-27

2. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C);eBioMedicine;2024-06

3. Environmental exposures as risk factors for idiopathic inflammatory myopathies;Journal of Autoimmunity;2023-11

4. New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review;Vaccines;2023-10-08

5. Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis;Medicina;2023-09-20